Hims & Hers Health is under scrutiny after its first Super Bowl ad drew criticism for allegedly misrepresenting compounded weight-loss medications. The Pharmaceutical Research and Manufacturers of America labeled the ad a violation of marketing regulations, stating it misrepresents the safety of the company's knockoff GLP-1 drugs. Hims & Hers defended the ad, arguing it aims to highlight the U.S. obesity crisis and offer affordable medication alternatives. The backlash indicates the firm's message resonates, despite the risks associated with compounded drugs not being FDA-approved.
Hims & Hers stated, 'We've called out the system and now the system is asking that our ad get taken down. This is a blatant attempt to shut down an ad that calls them out.'
The Pharmaceutical Research and Manufacturers of America criticized the ad, claiming it 'misrepresents the safety and efficacy of their knockoff GLP-1 medicines.'
Hims & Hers argues it's providing access to weight-loss medications, stating that compounded versions of drugs can assist those who can't afford expensive options.
While compounded drugs are often criticized due to contamination risks, proponents maintain they can offer high-quality alternatives to expensive brand-name drugs.
Collection
[
|
...
]